Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hetrombopag for MDS-related Thrombocytopenia
NCT05024877Phase 3Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Oct 2021
- Primary completion
- Oct 2023
- Countries
- 1
01
Overview
A Phase 3 trial of hetrombopag in Thrombocytopenia, sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
hetrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT05024877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05024877.